Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trialMarco Colleoni, Joanna Vermeij, Weixiu Luo et al.|The Lancet Oncology|2017Cited by 122
Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patientsAkihiko Osaki, Tetsuya Toge, Masakazu Toi et al.|The American Journal of Surgery|1992Cited by 72
Loss of VLA‐2 Collagen Receptor in Breast Carcinoma, Facilitating Invasion and MetastasisKoji Arihiro, Tetsuya Toge, Kouki Inai et al.|Japanese Journal of Cancer Research|1993Cited by 15
Effects of intraperitoneal administration of OK-432 for patients with advanced cancerTetsuya Toge, Takao Hattori, Hirofumi Yamada et al.|Surgery Today|1985Cited by 12
Relationship of the distribution of leu-2+ cells with suppressor cell activities in the spleen and lymphnodes from gastric cancerTetsuya Toge, Takao Hattori, Yoshihiro Seto et al.|Surgery Today|1987Cited by 9